Phase 1 HIV and AIDS Trial, Recruiting NCT07525544 Sponsor: ViiV Healthcare Condition: HIV and AIDS
Back to Hiv Aids

Phase 1 HIV and AIDS Trial, Recruiting

NCT07525544
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 55 years old
  • People with a body mass index (a measure of body weight relative to height) between 18.5 and 37.0
  • Male participants must agree to use contraception or abstain from sexual activity during the trial (confirm with trial site for specific requirements)
  • Female participants must not be pregnant or breastfeeding, and must be considered unable to become pregnant (confirm with trial site for how this is defined)

Who may not be able to join:

  • People with a significant medical history that could affect how the body processes the study drug, create health risks, or interfere with the trial
  • People with certain serious conditions affecting mental health, the liver, heart, digestive system, lungs, hormones, nervous system, blood, kidneys, or who have had certain cancers (confirm with trial site for specific conditions)
  • People who test positive for Hepatitis B, Hepatitis C, or HIV
  • People with a history of, or current, high-risk behaviours associated with acquiring HIV
  • People currently taking certain medications that are not permitted during the trial
  • People with certain allergies or sensitivities (confirm with trial site for specifics)
  • People who regularly use alcohol, recreational drugs, tobacco, or nicotine products
  • People who have recently participated in, or are currently participating in, another clinical trial (confirm with trial site for specific restrictions)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 877-379-3718

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
ViiV Healthcare
Registry
ClinicalTrials.gov
Start date
14 May 2026
Est. completion
5 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants with Grade 3 and Grade 4 adverse events (AEs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov